- Company News
Acetazolamide is a well-established carbonic anhydrase inhibitor widely used as an active pharmaceutical ingredient (API) in various therapeutic areas. At TCS GROUP, our acetazolamide offering meets high-purity standards, making it ideal for formulation into tablets, capsules, or parenteral systems. According to pharmacological data, acetazolamide functions by inhibiting the enzyme carbonic anhydrase, thereby reducing aqueous humor…
- Company News
Meet Us in CPHI (Frankfurt)
- Industry News
As the pharmaceutical sector accelerates into a post-pandemic era, the global API market is expected to reach unprecedented levels. Rising healthcare demands in emerging markets, the growth of biologics, and a strong generics pipeline are creating exciting opportunities for API manufacturers. However, challenges such as geopolitical uncertainty, stricter environmental regulations, and increased scrutiny from regulatory…
- Industry News
In the current pharmaceutical ecosystem, a delayed delivery or compromised batch can cost millions and damage credibility. This is why supply-chain reliability has become a critical driver of success rather than a back-end function. Companies that collaborate with consistent API partners enjoy guaranteed production timelines, predictable costs, and smoother regulatory processes. Such reliability allows marketing…
- Company News
Meet us at CPHI 2016!